Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution
Artificial Organs · 2026-07 · 50 (7) · 1027-1036
DOI: 10.1111/aor.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 28.04.2026. Verfasst von Gerti Dajti und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Liver Transplantation, Perfusion, Organ Preservation. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The advent of machine perfusion (MP) has significantly improved post‐liver transplantation (post‐LT) outcomes, potentially enabling the use of increasingly marginal grafts and expanding the organ donor pool.
Methods
We present a retrospective cohort study of consecutive adult patients who underwent LT between 2018 and 2023 at a leading Italian institution. The objective was to evaluate outcomes following the use of hypothermic oxygenated perfusion (HOPE) in high‐risk grafts.
Results
A total of 507 patients were included in the final analysis, of whom 420 (83%) received extended criteria donor (ECD) grafts. Among ECD grafts, 62 (15%) were from donation after circulatory death (DCD) donors, and 64 (15%) were previously discarded by other centers. HOPE was applied in 248 (49%) cases. Recipients in the HOPE group experienced significantly lower rates of early allograft dysfunction (EAD) (20% vs. 32%, p = 0.007), primary nonfunction (2% vs. 7%, p = 0.017), and severe postoperative complications (Clavien–Dindo grade ≥ 3b) (19% vs. 28%, p = 0.026). Notably, marginal grafts treated with HOPE achieved survival outcomes comparable to those of standard risk.
Conclusions
HOPE is associated with improved outcomes in LT using ECD grafts and can enable the safe use of higher‐risk organs with acceptable results when performed in experienced centers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
ORCID-Profile: Gerti Dajti, Giuliana Germinario, Enrico Prosperi, Guido Fallani, Chiara Bonatti, Edoardo Prosperi, Antonio Siniscalchi, Maria Cristina Morelli, Antonietta D' Errico, Matteo Serenari, Massimo Del Gaudio, Chiara Zanfi, Federica Odaldi, Lorenzo Maroni, Andrea Laurenzi, Matteo Cescon, Matteo Ravaioli
Zitieren
APA
Dajti, G., Germinario, G., Prosperi, E., Fallani, G., Bonatti, C., Prosperi, E., Siniscalchi, A., Morelli, M. C., D' Errico, A., Serenari, M., Del Gaudio, M., Zanfi, C., Odaldi, F., Maroni, L., Laurenzi, A., Cescon, M., & Ravaioli, M. (2026). Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution. Artificial Organs, 50(7), 1027-1036. https://doi.org/10.1111/aor.70137
Vancouver
Dajti G, Germinario G, Prosperi E, Fallani G, Bonatti C, Prosperi E, et al. Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution. Artificial Organs. 2026;50(7):1027-1036. doi:10.1111/aor.70137
BibTeX
@article{Dajti2026,
author = {Dajti, Gerti and Germinario, Giuliana and Prosperi, Enrico and Fallani, Guido and Bonatti, Chiara and Prosperi, Edoardo and Siniscalchi, Antonio and Morelli, Maria Cristina and D' Errico, Antonietta and Serenari, Matteo and Del Gaudio, Massimo and Zanfi, Chiara and Odaldi, Federica and Maroni, Lorenzo and Laurenzi, Andrea and Cescon, Matteo and Ravaioli, Matteo},
title = {Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution},
journal = {Artificial Organs},
year = {2026},
volume = {50},
number = {7},
pages = {1027--1036},
doi = {10.1111/aor.70137}
}
EUVIMED